Showing 8 of 8 recruiting trials for “neurotrophic-keratopathy”
Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
👨⚕️ Weiyun Shi, Ph.D, Shandong First Medical University Affiliated Eye Hospital📍 1 site📅 Started Jun 2025View details ↗
Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy
👨⚕️ Karim Mohamed-Noriega, M.D., Departamento de Oftalmologia, Hospital Universitario Dr. Jose Eleuterio Gonzalez📍 1 site📅 Started Nov 2020View details ↗
RecruitingNCT04573647 ↗
OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →